UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - gerald+lipshutz
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
AAV-Based Treatment of Guanidinoacetate Methyltransferase (GAMT) Deficiency (UCLA Case No. 2021-012)
SUMMARY: UCLA researchers in the Departments Molecular & Medical Pharmacology and Surgery in the David Geffen School of Medicine have developed a novel and tissue-specific gene therapy treatment for Guanidinoacetate methyltransferase (GAMT) deficiency. BACKGROUND: Guanidinoacetate Methyltransferase (GAMT) deficiency is caused by a mutation in...
Published: 8/10/2023
|
Inventor(s):
Gerald Lipshutz
Keywords(s):
Adeno-associated viruses (AAV)
,
Creatine
,
GAMT deficiency
,
Gene Therapy
,
Metabolic Diseases
Category(s):
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Genetic Diseases
,
Therapeutics > Metabolism And Endocrinology
2019-600 TREATMENT FOR RESTORING UREAGENESIS IN CARBAMOYL PHOSPHATE SYNTHETASE 1 DEFICIENCY
Treatment for Restoring Ureagenesis in Carbamoyl Phosphate Synthetase 1 DeficiencyTech ID: 30356 / UC Case 2019-600-0SUMMARYUCLA researchers in the Department of Surgery have developed a gene therapy to treat carbamoyl phosphate synthetase 1 deficiency.BACKGROUNDCarbamoyl phosphate synthetase 1 (CPS1) deficiency is an inherited autosomal recessive urea...
Published: 9/5/2023
|
Inventor(s):
Gerald Lipshutz
Keywords(s):
Cns
,
Gene Editing Systems
,
Gene Therapy
,
Genetic Disease
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Therapeutics > CNS and Neurology
,
Therapeutics > Gene Therapy And Editing
2019-550: A Method to Prevent the Myelin Abnormalities Associated with Arginase Deficiency
SUMMARY UCLA researchers in the Department of Surgery have developed a gene therapy to prevent dysmyelination (and other CNS abnormalities) as a result of arginase deficiency. BACKGROUND Arginase deficiency (ARG1 deficiency, argininemia) is an inherited autosomal recessive disorder caused by deficient/defective enzyme arginase 1 in the final...
Published: 9/5/2023
|
Inventor(s):
Gerald Lipshutz
Keywords(s):
Cns
,
Gene Editing Systems
,
Gene Therapy
,
Genetic Disease
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Therapeutics > CNS and Neurology
,
Therapeutics > Gene Therapy And Editing